North American renewable natural gas provider Clean Energy Fuels (NASDAQ:CLNE) hasn’t exactly been a darling of the markets lately. Unfortunately for the company’s investors, CLNE stock peaked in February and then sputtered out.
Source: ZikG / Shutterstock.com
Does this mean that the company is actually in trouble? Not necessarily. It’s possible that the share price just went up too far, too fast in early 2021.
Top 5 Clean Energy Stocks To Own Right Now: Rigel Pharmaceuticals Inc.(RIGL)
Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The company?s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.
Advisors’ Opinion:
- [By Max Byerly]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has been given a consensus rating of “Buy” by the ten analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $7.93.
- [By Brian Orelli]
Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) jumped 20.9% in August, according to data provided by S&P Global Market Intelligence as investors in the biotech become more comfortable with the potential of Tavalisse, Rigel’s recently approved drug for chronic immune thrombocytopenia, which is characterized by low blood platelet levels.
- [By Cory Renauer]
Here’s why analysts are willing to stick their necks out and predict huge gains ahead for these fledgling drugmakers. Just remember, huge potential rewards usually come with a great deal of risk.
Company (Symbol) Bank Recent Price Target Implied Upside at Recent Prices
Tocagen Inc. (NASDAQ:TOCA) Citigroup $27 141%
Vital Therapies, Inc. (NASDAQ:VTL) Cantor Fitzgerald $18 142%
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Citigroup $8.50156%
Top 5 Clean Energy Stocks To Own Right Now: Computer Task Group, Incorporated(CTG)
Computer Task Group, Incorporated operates as an information technology (IT) solutions and staffing services company in North America and Europe. Its IT solutions include the implementation and optimization of packaged software applications; development and deployment of customized software and solutions designed to fit the needs of a specific client or market; and design and distribution of complex technology components. The companys IT and other staffing solutions include recruiting, retaining, and managing IT and other talent primarily for technology service providers and companies with multiple locations. It also provides IT services for the healthcare provider market that include clinical systems integration and implementation, application management, technology support for medical imaging, training, and technical resources. The company serves technology service and healthcare providers, health insurers, and diversified industrials markets, as well as manufacturing, life sciences, and financial services companies. The company was founded in 1966 and is headquartered in Buffalo, New York.
